Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Athenex, Inc.

http://www.athenex.com/

Latest From Athenex, Inc.

Sanofi's Rilzabrutinib Fails At First Hurdle In Pemphigus Study

Analysts who felt Sanofi paid way over the odds when splashing out $3.7bn to buy Principia last year will be feeling justified in that stance after one of the oral BTK inhibitors acquired, rilzabrutinib, proved to be no more effective than placebo in a Phase III trial.

Immune Disorders Clinical Trials

Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal

Lilly partners with Kumquat to discover small molecule IO drug. Kite, Appia Bio collaborate on allogeneic cell therapies. AstraZeneca and Regeneron pursue novel metabolic therapies targeting GPR75. Lexeo and Stelios merge to focus on gene therapies for rare cardiovascular indications.

Deals M & A

Almirall Aims To Disrupt Actinic Keratosis Space With Klisyri

Helped by its convenient five-day dosing, the shortest of any topical treatment for the precancerous skin disease, the Spanish company believes Klisyri, already launched in the US, will become a popular alternative to current options for actinic keratosis.

Dermatology Drug Review

Obesity Drug Imcivree Among Eight New Products To Win EMA Nod

The European Medicines Agency today revealed the names of the latest new products it believes should be approved for use across the EU.

Europe Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • QuaDPharma, LLC., Kinex Pharmaceuticals, Axis Therapeutics Limited
    • Kuur Therapeutics, Inc.
UsernamePublicRestriction

Register